SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-004472
Filing Date
2015-12-10
Accepted
2015-12-10 16:47:47
Documents
9
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-103115.htm 10-Q 284145
2 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 7763
3 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 3791
  Complete submission text file 0001019687-15-004472.txt   2175269

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20151031.xml EX-101.INS 403357
5 XBRL SCHEMA FILE pmcb-20151031.xsd EX-101.SCH 22841
6 XBRL CALCULATION FILE pmcb-20151031_cal.xml EX-101.CAL 43804
7 XBRL DEFINITION FILE pmcb-20151031_def.xml EX-101.DEF 78420
8 XBRL LABEL FILE pmcb-20151031_lab.xml EX-101.LAB 191195
9 XBRL PRESENTATION FILE pmcb-20151031_pre.xml EX-101.PRE 156687
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 151281330
SIC: 2833 Medicinal Chemicals & Botanical Products